Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL 2023-09-21 20:26
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT 2023-09-21 19:30
Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031 2023-09-21 18:05
Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncology 2023-09-21 16:00
Yuyu Healthcare Conducts Global Promotion at Vitafoods Asia 2023 2023-09-21 14:06
Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB 2023-09-21 08:00
Everest Medicines Enters into Collaboration and License Agreement with Kezar Life Sciences to Develop and Commercialize Zetomipzomib in Greater China and other Asian Markets 2023-09-21 07:05
European Commission Approves Menarini Group's ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation 2023-09-20 23:27
Hepagene Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for HPG7233 THR Beta Agonist 2023-09-20 22:00
Taiwan's Premier Health Brand Unveils Best Quality Pineapple Enzyme for Digestive Health 2023-09-20 21:00
Double Honors: Sanyou Bio Earns "Most Trusted Biopharmaceutical CXO Partner" and "Most Influential Partner of the Year" Awards 2023-09-20 20:00
WuXi XDC Launches New Commercial Manufacturing Facilities 2023-09-20 18:51
The First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint 2023-09-20 15:52
AffaMed Therapeutics Announces First Patient Treated in Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery 2023-09-20 09:00
Everest Medicines Announces China Center for Drug Evaluation of NMPA Recommends Priority Review for Cefepime-Taniborbactam for the Treatment of Complicated Urinary Tract Infections, including Pyelonephritis 2023-09-20 08:26
Cerecin strengthens position in neurometabolism with addition to pipeline 2023-09-19 19:39
Caliway Announces the Completion of Subject Recruitment in the CBL-0201EFP Phase 2-stage 2 Study Evaluating the CBL-514 in Cellulite Treatment 2023-09-19 11:16
ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility 2023-09-19 09:16
Canton Biologics Completes Over 300 Million Yuan Series C Financing, Led by SDIC Venture Capital 2023-09-18 18:43
Biosyngen received the Asia Pacific Cell & Gene Therapy Excellence Awards (APCGTEA) 2023 2023-09-18 17:53
1 87 88 89 90 91 421